Difference between revisions of "LncRNAWiki:Featured"

From LncRNAWiki
Jump to: navigation, search
Line 12: Line 12:
 
|[[LINC02597]]
 
|[[LINC02597]]
 
|Transcriptional regulation
 
|Transcriptional regulation
 +
|_
 
|Pathogenic process
 
|Pathogenic process
 
|Postmenopausal osteoporosis (PMOP)
 
|Postmenopausal osteoporosis (PMOP)
Line 19: Line 20:
 
|[[UVRAG-DT]]
 
|[[UVRAG-DT]]
 
|Transcriptional regulation
 
|Transcriptional regulation
 +
|_
 
|Pathogenic process
 
|Pathogenic process
 
|Postmenopausal osteoporosis (PMOP)
 
|Postmenopausal osteoporosis (PMOP)
Line 25: Line 27:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185540 HSALNT0185540]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185540 HSALNT0185540]
 
|[[LINC02598]]
 
|[[LINC02598]]
 +
|_
 
|_
 
|_
 
|Pathogenic process
 
|Pathogenic process
Line 32: Line 35:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0278274 HSALNT0278274]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0278274 HSALNT0278274]
 
|[[SREBF2-AS1]]
 
|[[SREBF2-AS1]]
 +
|_
 
|_
 
|_
 
|Pathogenic process
 
|Pathogenic process
Line 39: Line 43:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021177 HSALNT0021177]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021177 HSALNT0021177]
 
|[[LINC02602]]
 
|[[LINC02602]]
 +
|_
 
|_
 
|_
 
|Pathogenic process
 
|Pathogenic process
Line 47: Line 52:
 
|[[MIR205HG]]
 
|[[MIR205HG]]
 
|CeRNA
 
|CeRNA
 +
|_
 
|Pathogenic process
 
|Pathogenic process
 
|Head & neck squamous cell carcinoma (HNSCC)
 
|Head & neck squamous cell carcinoma (HNSCC)
Line 54: Line 60:
 
|[[ZNF451-AS1]]
 
|[[ZNF451-AS1]]
 
|Transcriptional regulation
 
|Transcriptional regulation
 +
|_
 
|Pathogenic process
 
|Pathogenic process
 
|Pancreatic ductal adenocarcinoma (PDAC)
 
|Pancreatic ductal adenocarcinoma (PDAC)
Line 60: Line 67:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189537 HSALNT0189537]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189537 HSALNT0189537]
 
|[[SCAT2]]
 
|[[SCAT2]]
 +
|_
 
|_
 
|_
 
|Pathogenic process
 
|Pathogenic process
Line 67: Line 75:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0107867 HSALNT0107867]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0107867 HSALNT0107867]
 
|[[SCAT8]]
 
|[[SCAT8]]
 +
|_
 
|_
 
|_
 
|Pathogenic process
 
|Pathogenic process
Line 75: Line 84:
 
|[[LINC00707]]
 
|[[LINC00707]]
 
|Transcriptional regulation
 
|Transcriptional regulation
 +
|_
 
|Pathogenic process
 
|Pathogenic process
 
|Lung cancer (LC) 
 
|Lung cancer (LC) 
Line 81: Line 91:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185476 HSALNT0185476]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185476 HSALNT0185476]
 
|[[LINC02470]]
 
|[[LINC02470]]
 +
|_
 
|_
 
|_
 
|Pathogenic process
 
|Pathogenic process
Line 88: Line 99:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0068302 HSALNT0068302]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0068302 HSALNT0068302]
 
|[[LINC02600]]
 
|[[LINC02600]]
 +
|_
 
|_
 
|_
 
|Pathogenic process
 
|Pathogenic process
Line 96: Line 108:
 
|[[LINC02604]]
 
|[[LINC02604]]
 
|CeRNA
 
|CeRNA
 +
|_
 
|Pathogenic process
 
|Pathogenic process
 
|Glioblastoma  
 
|Glioblastoma  
Line 103: Line 116:
 
|[[MACORIS]]
 
|[[MACORIS]]
 
|Transcriptional regulation
 
|Transcriptional regulation
 +
|_
 
|_
 
|_
 
|Cardiometabolic Diseases
 
|Cardiometabolic Diseases
Line 110: Line 124:
 
|[[KRTAP5-AS1]]
 
|[[KRTAP5-AS1]]
 
|CeRNA
 
|CeRNA
 +
|_
 
|Pathogenic process
 
|Pathogenic process
 
|Gastric Cancer
 
|Gastric Cancer
Line 116: Line 131:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215076 HSALNT0215076]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215076 HSALNT0215076]
 
|[[GSC-DT]]
 
|[[GSC-DT]]
 +
|_
 
|_
 
|_
 
| Developmental process
 
| Developmental process
Line 124: Line 140:
 
|[[CHAER1]]
 
|[[CHAER1]]
 
|Translational control
 
|Translational control
 +
|_
 
|Pathogenic process
 
|Pathogenic process
 
|Cardiac hypertrophy
 
|Cardiac hypertrophy
Line 131: Line 148:
 
|[[ODC1-DT]]
 
|[[ODC1-DT]]
 
|CeRNA
 
|CeRNA
 +
|_
 
|Pathogenic process
 
|Pathogenic process
 
|Head and neck carcinoma 
 
|Head and neck carcinoma 
Line 137: Line 155:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0039409 HSALNT0039409]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0039409 HSALNT0039409]
 
|[[MAP3K2-DT]]
 
|[[MAP3K2-DT]]
 +
|_
 
|_
 
|_
 
|Pathogenic process
 
|Pathogenic process
Line 145: Line 164:
 
|[[ZFHX2-AS1]]
 
|[[ZFHX2-AS1]]
 
|Transcriptional regulation
 
|Transcriptional regulation
 +
|_
 
|Developmental process
 
|Developmental process
 
|_
 
|_
Line 151: Line 171:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0152349 HSALNT0152349]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0152349 HSALNT0152349]
 
|[[LINC02603]]
 
|[[LINC02603]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 158: Line 179:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0081596 HSALNT0081596]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0081596 HSALNT0081596]
 
|[[TENM3-AS1]]
 
|[[TENM3-AS1]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 165: Line 187:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0165522 HSALNT0165522]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0165522 HSALNT0165522]
 
|[[LINC00858]]
 
|[[LINC00858]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 172: Line 195:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281930 HSALNT0281930]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281930 HSALNT0281930]
 
|[[SCAT1]]
 
|[[SCAT1]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 179: Line 203:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0191750 HSALNT0191750]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0191750 HSALNT0191750]
 
|[[LNCOG]]
 
|[[LNCOG]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 186: Line 211:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246388 HSALNT0246388]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246388 HSALNT0246388]
 
|[[DCXR-DT]]
 
|[[DCXR-DT]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 193: Line 219:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209659 HSALNT0209659]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209659 HSALNT0209659]
 
|[[NKX2-1-AS1]]
 
|[[NKX2-1-AS1]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 200: Line 227:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0038250 HSALNT0038250]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0038250 HSALNT0038250]
 
|[[ACTR3-AS1]]
 
|[[ACTR3-AS1]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 207: Line 235:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043145 HSALNT0043145]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043145 HSALNT0043145]
 
|[[ITGA6-AS1]]
 
|[[ITGA6-AS1]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 214: Line 243:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281822 HSALNT0281822]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281822 HSALNT0281822]
 
|[[LINC02601]]
 
|[[LINC02601]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 221: Line 251:
 
|_
 
|_
 
|[[ZKSCAN7-AS1]]
 
|[[ZKSCAN7-AS1]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 228: Line 259:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120721 HSALNT0120721]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120721 HSALNT0120721]
 
|[[GARS-DT ]]
 
|[[GARS-DT ]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 235: Line 267:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0093136 HSALNT0093136]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0093136 HSALNT0093136]
 
|[[LINCADL]]
 
|[[LINCADL]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 242: Line 275:
 
|_
 
|_
 
|[[GPRACR]]
 
|[[GPRACR]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 249: Line 283:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0082561 HSALNT0082561]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0082561 HSALNT0082561]
 
|[[LINC01060]]
 
|[[LINC01060]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 256: Line 291:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0058704 HSALNT0058704]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0058704 HSALNT0058704]
 
|[[TBILA]]
 
|[[TBILA]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 263: Line 299:
 
|_
 
|_
 
|[[UGDH-AS1]]
 
|[[UGDH-AS1]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 270: Line 307:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245777 HSALNT0245777]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245777 HSALNT0245777]
 
|[[TNRC6C-AS1]]
 
|[[TNRC6C-AS1]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 277: Line 315:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0225753 HSALNT0225753]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0225753 HSALNT0225753]
 
|[[LINC02244]]
 
|[[LINC02244]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 284: Line 323:
 
|_
 
|_
 
|[[NKAIN3-IT1]]
 
|[[NKAIN3-IT1]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 291: Line 331:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013113 HSALNT0013113]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013113 HSALNT0013113]
 
|[[NGF-AS1]]
 
|[[NGF-AS1]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 298: Line 339:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0031057 HSALNT0031057]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0031057 HSALNT0031057]
 
|[[LINC01121]]
 
|[[LINC01121]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 305: Line 347:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234176 HSALNT0234176]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234176 HSALNT0234176]
 
|[[ARLNC1]]
 
|[[ARLNC1]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 312: Line 355:
 
|_
 
|_
 
|[[MPPED2-AS1]]
 
|[[MPPED2-AS1]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 319: Line 363:
 
|_
 
|_
 
|[[ZKSCAN2-DT]]
 
|[[ZKSCAN2-DT]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 326: Line 371:
 
|_
 
|_
 
|[[LINC01703]]
 
|[[LINC01703]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 333: Line 379:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144162 HSALNT0144162]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144162 HSALNT0144162]
 
|[[HPYR1]]
 
|[[HPYR1]]
 +
|_
 
|_
 
|_
 
|pathogenic process
 
|pathogenic process
Line 341: Line 388:
 
|[[LINC00958]]
 
|[[LINC00958]]
 
|protein localization,transcriptional regulation
 
|protein localization,transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|bladder cancer, glioma
 
|bladder cancer, glioma
Line 348: Line 396:
 
|[[SH3PXD2A-AS1]]
 
|[[SH3PXD2A-AS1]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|colorectal cancer
 
|colorectal cancer
Line 355: Line 404:
 
|[[SSTR5-AS1]]
 
|[[SSTR5-AS1]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|neuroendocrine prostate cancer
 
|neuroendocrine prostate cancer
Line 361: Line 411:
 
|_
 
|_
 
|[[TSPOAP1-AS1]]
 
|[[TSPOAP1-AS1]]
 +
|_
 
|_
 
|_
 
|pathogenic process
 
|pathogenic process
Line 369: Line 420:
 
|[[LINC00174]]
 
|[[LINC00174]]
 
|ceRNA
 
|ceRNA
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|colorectal carcinoma
 
|colorectal carcinoma
Line 376: Line 428:
 
|[[LINC01561]]
 
|[[LINC01561]]
 
|ceRNA
 
|ceRNA
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|breast cancer
 
|breast cancer
Line 383: Line 436:
 
|[[LINC00514]]
 
|[[LINC00514]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|neuroendocrine prostate cancer
 
|neuroendocrine prostate cancer
Line 389: Line 443:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282164 HSALNT0282164]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282164 HSALNT0282164]
 
|[[LINC02595]]
 
|[[LINC02595]]
 +
|_
 
|_
 
|_
 
|pathogenic process
 
|pathogenic process
Line 396: Line 451:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197396 HSALNT0197396]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197396 HSALNT0197396]
 
|[[FZD10-AS1]]
 
|[[FZD10-AS1]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 404: Line 460:
 
|[[LINC01567]]
 
|[[LINC01567]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|colon cancer
 
|colon cancer
Line 411: Line 468:
 
|[[ADPGK-AS1]]
 
|[[ADPGK-AS1]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|pancreatic cancer
 
|pancreatic cancer
Line 418: Line 476:
 
|[[RAB11B-AS1]]
 
|[[RAB11B-AS1]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|osteosarcoma
 
|osteosarcoma
Line 425: Line 484:
 
|[[SNHG29]]
 
|[[SNHG29]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|acute myeloid leukemia, rheumatoid arthritis  
 
|acute myeloid leukemia, rheumatoid arthritis  
Line 432: Line 492:
 
|[[SNHG17]]
 
|[[SNHG17]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|colorectal cancer
 
|colorectal cancer
Line 439: Line 500:
 
|[[DICER1-AS1]]
 
|[[DICER1-AS1]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|osteosarcoma
 
|osteosarcoma
Line 446: Line 508:
 
|[[TTN-AS1]]
 
|[[TTN-AS1]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|esophageal squamous cell carcinoma
 
|esophageal squamous cell carcinoma
Line 453: Line 516:
 
|[[LINC00092]]
 
|[[LINC00092]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|ovarian cancer
 
|ovarian cancer
Line 460: Line 524:
 
|[[THUMPD3-AS1]]
 
|[[THUMPD3-AS1]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|Neuron death in stroke
 
|Neuron death in stroke
Line 467: Line 532:
 
|[[LINC00554]]
 
|[[LINC00554]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|liver cancer
 
|liver cancer
Line 474: Line 540:
 
|[[ZFPM2-AS1]]
 
|[[ZFPM2-AS1]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|multiple cancers, gastric carcinogenesis
 
|multiple cancers, gastric carcinogenesis
Line 481: Line 548:
 
|[[HOXB-AS1]]
 
|[[HOXB-AS1]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|autosomal dominant polycistic kidney disease
 
|autosomal dominant polycistic kidney disease
Line 488: Line 556:
 
|[[CFAP58-DT]]
 
|[[CFAP58-DT]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|innate immune response to viral infection
 
|innate immune response to viral infection
Line 494: Line 563:
 
|_
 
|_
 
|[[FAM230A]]
 
|[[FAM230A]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 502: Line 572:
 
|[[CPNE8-AS1]]
 
|[[CPNE8-AS1]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|cervical cancer
 
|cervical cancer
Line 509: Line 580:
 
|[[THORLNC]]
 
|[[THORLNC]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|melanoma, skin squamous cell carcinoma,osteosarcoma, renal cell carcinoma  
 
|melanoma, skin squamous cell carcinoma,osteosarcoma, renal cell carcinoma  
Line 516: Line 588:
 
|[[IATPR]]
 
|[[IATPR]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|breast cancer, gallbladder cancer
 
|breast cancer, gallbladder cancer
Line 523: Line 596:
 
|[[PICART1]]
 
|[[PICART1]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|breast cancer, colorectal cancer, lung cancer
 
|breast cancer, colorectal cancer, lung cancer
Line 530: Line 604:
 
|[[LINC02599]]
 
|[[LINC02599]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|breast cancer
 
|breast cancer
Line 537: Line 612:
 
|[[ETS1-AS1]]
 
|[[ETS1-AS1]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|gastric cancer, neuroblastoma
 
|gastric cancer, neuroblastoma
Line 544: Line 620:
 
|[[MAPK6-DT]]
 
|[[MAPK6-DT]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|liver cancer
 
|liver cancer
Line 551: Line 628:
 
|[[IL1R1-AS1]]
 
|[[IL1R1-AS1]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|Oral squamous cell carcinoma, breast cancer
 
|Oral squamous cell carcinoma, breast cancer
Line 558: Line 636:
 
|[[LINC01672]]
 
|[[LINC01672]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
| Esophageal squamous cell carcinoma
 
| Esophageal squamous cell carcinoma
Line 565: Line 644:
 
|[[SIRLNT]]
 
|[[SIRLNT]]
 
|ceRNA
 
|ceRNA
 +
|_
 
|pathogenic process
 
|pathogenic process
 
| Breast cancer
 
| Breast cancer
Line 572: Line 652:
 
|[[LINC01605]]
 
|[[LINC01605]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|Colon Cancer, Bladder cancer
 
|Colon Cancer, Bladder cancer
Line 579: Line 660:
 
|[[GAU1]]
 
|[[GAU1]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|Neuroblastoma and retinoblastoma
 
|Neuroblastoma and retinoblastoma
Line 586: Line 668:
 
|[[LINC00894]]
 
|[[LINC00894]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|Lung adenocarcinoma
 
|Lung adenocarcinoma
Line 592: Line 675:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0000250 HSALNT0000250]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0000250 HSALNT0000250]
 
|[[LINC02593]]
 
|[[LINC02593]]
 +
|_
 
|_
 
|_
 
|pathogenic process
 
|pathogenic process
Line 599: Line 683:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0241060 HSALNT0241060]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0241060 HSALNT0241060]
 
|[[LINC02594]]
 
|[[LINC02594]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 607: Line 692:
 
|[[LINC01705]]
 
|[[LINC01705]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|gastric cancer
 
|gastric cancer
Line 614: Line 700:
 
|[[LINC02474]]
 
|[[LINC02474]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|gastric cancer
 
|gastric cancer
Line 621: Line 708:
 
|[[LINC02590]]
 
|[[LINC02590]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|gastric cancer
 
|gastric cancer
Line 628: Line 716:
 
|[[MUC5B-AS1]]
 
|[[MUC5B-AS1]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
| lung adenocarcinoma
 
| lung adenocarcinoma
Line 634: Line 723:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275151 HSALNT0275151]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275151 HSALNT0275151]
 
|[[FAM230D]]
 
|[[FAM230D]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 641: Line 731:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275163  HSALNT0275163 ]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275163  HSALNT0275163 ]
 
|[[FAM230E]]
 
|[[FAM230E]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 648: Line 739:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275179  HSALNT0275179 ]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275179  HSALNT0275179 ]
 
|[[FAM230F]]
 
|[[FAM230F]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 655: Line 747:
 
|_
 
|_
 
|[[FAM230G]]
 
|[[FAM230G]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 662: Line 755:
 
|_
 
|_
 
|[[FAM230H]]
 
|[[FAM230H]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 669: Line 763:
 
|_
 
|_
 
|[[FAM230I]]
 
|[[FAM230I]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 676: Line 771:
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275150 HSALNT0275150]
 
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275150 HSALNT0275150]
 
|[[FAM230J]]
 
|[[FAM230J]]
 +
|_
 
|_
 
|_
 
|_
 
|_
Line 684: Line 780:
 
|[[HCG14]]
 
|[[HCG14]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|Celiac disease,  Nutritional and Metabolic Diseases
 
|Celiac disease,  Nutritional and Metabolic Diseases
Line 691: Line 788:
 
|[[LNCTAM34A]]
 
|[[LNCTAM34A]]
 
|ceRNA
 
|ceRNA
 +
|_
 
|developmental process
 
|developmental process
 
|Colon Cancer
 
|Colon Cancer
Line 698: Line 796:
 
|[[LINC01510]]
 
|[[LINC01510]]
 
|transcriptional regulation, ceRNA
 
|transcriptional regulation, ceRNA
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|Colorectal cancer, Non-small cell lung cancer
 
|Colorectal cancer, Non-small cell lung cancer
Line 705: Line 804:
 
|[[LNCOC1]]
 
|[[LNCOC1]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|Ovarian cancer
 
|Ovarian cancer
Line 712: Line 812:
 
|[[LGALSL-DT]]
 
|[[LGALSL-DT]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|Postmenopausal osteoporosis (PMOP)
 
|Postmenopausal osteoporosis (PMOP)
Line 719: Line 820:
 
|[[LINC02596]]
 
|[[LINC02596]]
 
|transcriptional regulation
 
|transcriptional regulation
 +
|_
 
|pathogenic process
 
|pathogenic process
 
|Postmenopausal osteoporosis (PMOP)
 
|Postmenopausal osteoporosis (PMOP)

Revision as of 06:24, 29 August 2019

LncBook ID Symbol Synonyms Functional Mechanism Biological Process Disease Mesh Ontology
HSALNT0267755 LINC02597 Transcriptional regulation _ Pathogenic process Postmenopausal osteoporosis (PMOP) Musculoskeletal Diseases
HSALNT0178412 UVRAG-DT Transcriptional regulation _ Pathogenic process Postmenopausal osteoporosis (PMOP) Musculoskeletal Diseases
HSALNT0185540 LINC02598 _ _ Pathogenic process Lung squamous cell carcinoma (LUSC) Neoplasms; Respiratory Tract Diseases
HSALNT0278274 SREBF2-AS1 _ _ Pathogenic process Lung squamous cell carcinoma (LUSC) Neoplasms; Respiratory Tract Diseases
HSALNT0021177 LINC02602 _ _ Pathogenic process Non-small cell lung cancer (NSCLC)  Neoplasms; Respiratory Tract Diseases
HSALNT0021052 MIR205HG CeRNA _ Pathogenic process Head & neck squamous cell carcinoma (HNSCC) Neoplasms
HSALNT0107588 ZNF451-AS1 Transcriptional regulation _ Pathogenic process Pancreatic ductal adenocarcinoma (PDAC) Neoplasms
HSALNT0189537 SCAT2 _ _ Pathogenic process Kidney clear cell carcinoma (KIRC) Neoplasm
HSALNT0107867 SCAT8 _ _ Pathogenic process Kidney clear cell carcinoma (KIRC) Neoplasm
HSALNT0158500 LINC00707 Transcriptional regulation _ Pathogenic process Lung cancer (LC)  Neoplasms; Respiratory Tract Diseases
HSALNT0185476 LINC02470 _ _ Pathogenic process Non-small cell lung cancer (NSCLC) and overian cancer Neoplasm
HSALNT0068302 LINC02600 _ _ Pathogenic process Non-small cell lung cancer (NSCLC) and overian cancer Neoplasm
HSALNT0123915 LINC02604 CeRNA _ Pathogenic process Glioblastoma Neoplasms
HSALNT0160932 MACORIS Transcriptional regulation _ _ Cardiometabolic Diseases Cardiovascular Diseases
HSALNT0171022 KRTAP5-AS1 CeRNA _ Pathogenic process Gastric Cancer Neoplasms; Digestive System Diseases
HSALNT0215076 GSC-DT _ _  Developmental process _ _
HSALNT0072605 CHAER1 Translational control _ Pathogenic process Cardiac hypertrophy Cardiovascular Diseases
HSALNT0027291 ODC1-DT CeRNA _ Pathogenic process Head and neck carcinoma  Neoplasm
HSALNT0039409 MAP3K2-DT _ _ Pathogenic process Polycystic ovary syndrome (PCOS) Female Urogenital Diseases and Pregnancy Complications
HSALNT0208284 ZFHX2-AS1 Transcriptional regulation _ Developmental process _ _
HSALNT0152349 LINC02603 _ _ _ _ _
HSALNT0081596 TENM3-AS1 _ _ _ _ _
HSALNT0165522 LINC00858 _ _ _ non-small cell lung cancer  Respiratory Tract Diseases
HSALNT0281930 SCAT1 _ _ _ esophagal cancer Digestive system Diseases
HSALNT0191750 LNCOG _ _ _ osteogenic differenciation Musculoskeletal Diseases
HSALNT0246388 DCXR-DT _ _ _ prostate cancer Male Urogenital Diseases
HSALNT0209659 NKX2-1-AS1 _ _ _ lung cancer  Respiratory Tract Diseases
HSALNT0038250 ACTR3-AS1 _ _ _ glioblastoma Nervous system diseases
HSALNT0043145 ITGA6-AS1 _ _ _ glioblastoma Nervous system diseases
HSALNT0281822 LINC02601 _ _ _ glioblastoma Nervous system diseases
_ ZKSCAN7-AS1 _ _ _ glioblastoma Nervous system diseases
HSALNT0120721 GARS-DT _ _ _ heroine addiction Nervous system diseases
HSALNT0093136 LINCADL _ _ _ obesity Digestive system Diseases
_ GPRACR _ _ _ liver cancer Digestive system Diseases
HSALNT0082561 LINC01060 _ _ _ pancreatic cancer Digestive system Diseases
HSALNT0058704 TBILA _ _ _ non-small cell lung cancer  Respiratory Tract Diseases
_ UGDH-AS1 _ _ _ invertebral disc degeneration Musculoskeletal Diseases
HSALNT0245777 TNRC6C-AS1 _ _ _ Thyroid cancer Endocrine system Disease
HSALNT0225753 LINC02244 _ _ _ obesity Digestive system Diseases
_ NKAIN3-IT1 _ _ _ glioblastoma Nervous system diseases
HSALNT0013113 NGF-AS1 _ _ _ dysmenorhea Female Urogenital Diseases
HSALNT0031057 LINC01121 _ _ _ pancreatic cancer Digestive system Diseases
HSALNT0234176 ARLNC1 _ _ _ prostate cancer Male Urogenital Diseases
_ MPPED2-AS1 _ _ _ thyroid neoplasias Endocrine system Disease
_ ZKSCAN2-DT _ _ _ Hepatocellular carcinoma Digestive system Diseases
_ LINC01703 _ _ _ Hepatocellular carcinoma Digestive system Diseases
HSALNT0144162 HPYR1 _ _ pathogenic process H. pylori infection _
HSALNT0172266 LINC00958 protein localization,transcriptional regulation _ pathogenic process bladder cancer, glioma _
HSALNT0167574 SH3PXD2A-AS1 transcriptional regulation _ pathogenic process colorectal cancer _
_ SSTR5-AS1 transcriptional regulation _ pathogenic process neuroendocrine prostate cancer _
_ TSPOAP1-AS1 _ _ pathogenic process breast cancer _
_ LINC00174 ceRNA _ pathogenic process colorectal carcinoma _
HSALNT0169064 LINC01561 ceRNA _ pathogenic process breast cancer _
_ LINC00514 transcriptional regulation _ pathogenic process neuroendocrine prostate cancer _
HSALNT0282164 LINC02595 _ _ pathogenic process colorectal cancer _
HSALNT0197396 FZD10-AS1 _ _ _ _ _
_ LINC01567 transcriptional regulation _ pathogenic process colon cancer _
_ ADPGK-AS1 transcriptional regulation _ pathogenic process pancreatic cancer _
HSALNT0255381 RAB11B-AS1 transcriptional regulation _ pathogenic process osteosarcoma _
HSALNT0237805 SNHG29 transcriptional regulation _ pathogenic process acute myeloid leukemia, rheumatoid arthritis _
_ SNHG17 transcriptional regulation _ pathogenic process colorectal cancer _
HSALNT0215138 DICER1-AS1 transcriptional regulation _ pathogenic process osteosarcoma _
HSALNT0043929 TTN-AS1 transcriptional regulation _ pathogenic process esophageal squamous cell carcinoma _
HSALNT0152594 LINC00092 transcriptional regulation _ pathogenic process ovarian cancer _
HSALNT0050704 THUMPD3-AS1 transcriptional regulation _ pathogenic process Neuron death in stroke _
HSALNT0205980 LINC00554 transcriptional regulation _ pathogenic process liver cancer _
HSALNT0141703 ZFPM2-AS1 transcriptional regulation _ pathogenic process multiple cancers, gastric carcinogenesis _
_ HOXB-AS1 transcriptional regulation _ pathogenic process autosomal dominant polycistic kidney disease _
HSALNT0167650 CFAP58-DT transcriptional regulation _ pathogenic process innate immune response to viral infection _
_ FAM230A _ _ _ _ _
_ CPNE8-AS1 transcriptional regulation _ pathogenic process cervical cancer _
_ THORLNC transcriptional regulation _ pathogenic process melanoma, skin squamous cell carcinoma,osteosarcoma, renal cell carcinoma _
_ IATPR transcriptional regulation _ pathogenic process breast cancer, gallbladder cancer _
HSALNT0242280 PICART1 transcriptional regulation _ pathogenic process breast cancer, colorectal cancer, lung cancer _
_ LINC02599 transcriptional regulation _ pathogenic process breast cancer _
HSALNT0183231 ETS1-AS1 transcriptional regulation _ pathogenic process gastric cancer, neuroblastoma _
_ MAPK6-DT transcriptional regulation _ pathogenic process liver cancer _
HSALNT0036655 IL1R1-AS1 transcriptional regulation _ pathogenic process Oral squamous cell carcinoma, breast cancer _
HSALNT0001134 LINC01672 transcriptional regulation _ pathogenic process Esophageal squamous cell carcinoma _
HSALNT0135857 SIRLNT ceRNA _ pathogenic process Breast cancer _
HSALNT0135484 LINC01605 transcriptional regulation _ pathogenic process Colon Cancer, Bladder cancer _
HSALNT0184552 GAU1 transcriptional regulation _ pathogenic process Neuroblastoma and retinoblastoma _
HSALNT0287294 LINC00894 transcriptional regulation _ pathogenic process Lung adenocarcinoma _
HSALNT0000250 LINC02593 _ _ pathogenic process breast cancer, hepatocellular carcinoma _
HSALNT0241060 LINC02594 _ _ _ gastric cancer _
HSALNT0022481 LINC01705 transcriptional regulation _ pathogenic process gastric cancer _
HSALNT0022477 LINC02474 transcriptional regulation _ pathogenic process gastric cancer _
HSALNT0030809 LINC02590 transcriptional regulation _ pathogenic process gastric cancer _
HSALNT0170966 MUC5B-AS1 transcriptional regulation _ pathogenic process lung adenocarcinoma _
HSALNT0275151 FAM230D _ _ _ _ _
HSALNT0275163 FAM230E _ _ _ _ _
HSALNT0275179 FAM230F _ _ _ _ _
_ FAM230G _ _ _ _ _
_ FAM230H _ _ _ Papillary thyroid carcinoma _
_ FAM230I _ _ _ _ _
HSALNT0275150 FAM230J _ _ _ _ _
HSALNT0103387 HCG14 transcriptional regulation _ pathogenic process Celiac disease, Nutritional and Metabolic Diseases _
HSALNT0001419 LNCTAM34A ceRNA _ developmental process Colon Cancer _
_ LINC01510 transcriptional regulation, ceRNA _ pathogenic process Colorectal cancer, Non-small cell lung cancer _
_ LNCOC1 transcriptional regulation _ pathogenic process Ovarian cancer _
_ LGALSL-DT transcriptional regulation _ pathogenic process Postmenopausal osteoporosis (PMOP) _
HSALNT0002862 LINC02596 transcriptional regulation _ pathogenic process Postmenopausal osteoporosis (PMOP) _
_ DEC1 _ _ _ _ _ _ RN7SK _ _ _ _ _ _ RN7SL1 _ _ _ _ _ _ MYOPARR _ _ _ _ _ _ PCED1B-AS1 _ _ _ _ _ _ UMLILO _ _ _ _ _ _ LINC02631 _ _ _ _ _ _ BMNCR _ _ _ _ _ _ ZEBTR _ _ _ _ _ _ SNHG31 _ _ _ _ _ _ ILF3-DT _ _ _ _ _ _ LINC00574 _ _ _ _ _ _ CEBPA-DT _ _ _ _ _ _ BABAM2-AS1 _ _ _ _ _ _ [[]] _ _ _ _ _ _ SNHG30 _ _ _ _ _ _ RCC2-AS1 _ _ _ _ _ _ NIPBL-DT _ _ _ _ _ _ PRDM16-DT _ _ _ _ _ _ BCL6-AS1 _ _ _ _ _ _ C1orf220 _ _ _ _ _ _ MIR122HG _ _ _ _ _ _ RB1-DT _ _ _ _ _ _ PANTR1 _ _ _ _ _ _ C11orf72 _ _ _ _ _ _ CT66 _ _ _ _ _ _ CAPN10-DT _ _ _ _ _ _ MIR1915HG _ _ _ _ _ _ CT75 _ _ _ _ _ _ [[]] _ _ _ _ _ _ MIR9-3HG _ _ _ _ _ _ RN7SL2 _ _ _ _ _ _ RN7SL3 _ _ _ _ _ _ CT70 _ _ _ _ _ _ CT69 _ _ _ _ _ _ FLVCR1-DT _ _ _ _ _ _ C10orf91 _ _ _ _ _ _ CEP83-DT _ _ _ _ _ _ CSTF3-DT _ _ _ _ _ _ CTBP1-DT _ _ _ _ _ _ FAM201B _ _ _ _ _ _ MAFG-DT _ _ _ _ _ _ RPP38-DT _ _ _ _ _ _ CDRT3 _ _ _ _ _ _ DLEU2L _ _ _ _ _
Retrieved from "https://ngdc.cncb.ac.cn/lncrnawiki1/index.php?title=LncRNAWiki:Featured&oldid=1276572"